Page last updated: 2024-09-05

mk 0852 and eptifibatide

mk 0852 has been researched along with eptifibatide in 2 studies

Compound Research Comparison

Studies (mk 0852)	Trials (mk 0852)	Recent Studies (post-2010) (mk 0852)	Studies (eptifibatide)	Trials (eptifibatide)	Recent Studies (post-2010) (eptifibatide)
17	2	0	907	220	212

Protein Interaction Comparison

Protein	Taxonomy	mk 0852 (IC50)	eptifibatide (IC50)
Integrin beta-3	Homo sapiens (human)		0.226
Integrin alpha-IIb	Homo sapiens (human)		0.226

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heptinstall, S; Storey, RF; Wilcox, RG	1
Lages, B; Weiss, HJ	1

Trials

1 trial(s) available for mk 0852 and eptifibatide

Article	Year
Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation, 1998, Oct-20, Volume: 98, Issue:16 Topics: Adenosine Diphosphate; Anticoagulants; Citrates; Collagen; Eptifibatide; Hirudins; Humans; Nephelometry and Turbidimetry; Oligopeptides; Peptides; Peptides, Cyclic; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sodium Citrate; Thiazolidines	1998

Article

Year

Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists.

Circulation, 1998, Oct-20, Volume: 98, Issue:16

Topics: Adenosine Diphosphate; Anticoagulants; Citrates; Collagen; Eptifibatide; Hirudins; Humans; Nephelometry and Turbidimetry; Oligopeptides; Peptides; Peptides, Cyclic; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sodium Citrate; Thiazolidines

1998

Other Studies

1 other study(ies) available for mk 0852 and eptifibatide

Article	Year
Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors. British journal of haematology, 2001, Volume: 113, Issue:1 Topics: Abciximab; Antibodies, Monoclonal; Blood Platelets; Calcium; Cytosol; Enzyme Inhibitors; Eptifibatide; Fura-2; Humans; Immunoglobulin Fab Fragments; Immunoglobulin Fragments; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin	2001

Article

Year

Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors.

British journal of haematology, 2001, Volume: 113, Issue:1

Topics: Abciximab; Antibodies, Monoclonal; Blood Platelets; Calcium; Cytosol; Enzyme Inhibitors; Eptifibatide; Fura-2; Humans; Immunoglobulin Fab Fragments; Immunoglobulin Fragments; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin

2001